Finder's Pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
The COVID-19 pandemic triggered massive volatility in the stock market, with increased instability in recent weeks as surging cases have led to a rush of people looking for tests. We've rounded up 9 stocks in companies that produce or sell COVID tests.
The best stocks depend on your portfolio and investment goals. While volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
Abbott Laboratories stock opened the day at $134.88 after a previous close of $135.14. The latest price was $135.56 (25 minute delay). Abbott Laboratories is listed on the NYSE, has a trailing 12-month revenue of around USD42.3 billion and employs 109,000 staff.
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine.
Quidel Corporation stock opened the day at $122.34 after a previous close of $121.25. The latest price was $123.00 (25 minute delay). Quidel Corporation is listed on the NASDAQ, has a trailing 12-month revenue of around USD$1.9 billion and employs 1,370 staff.
Cue Health Inc. , a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for public sectors, healthcare providers, large enterprises, and individual consumers. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System comprising a portable and reusable reader (Cue Reader), a single-use test cartridge (Cue Cartridge), and a sample collection wand (Cue Wand); Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows for integrations with third-party applications and sensors.
Cue Health IncCommon Stock stock opened the day at $9.80 after a previous close of $9.79. The latest price was $9.27 (25 minute delay). Cue Health IncCommon Stock is listed on the NASDAQ, has a trailing 12-month revenue of around USD$438.9 million and employs 1,290 staff.
Lucira Health, Inc. , a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services.
Lucira Health stock opened the day at $6.56 after a previous close of $6.58. The latest price was $8.50 (25 minute delay). Lucira Health is listed on the NASDAQ, has a trailing 12-month revenue of around USD$32.2 million and employs 102 staff.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International.
Walgreens Boots Alliance stock opened the day at $49.61 after a previous close of $49.17. The latest price was $49.50 (25 minute delay). Walgreens Boots Alliance is listed on the NASDAQ, has a trailing 12-month revenue of around USD$135 billion and employs 202,000 staff.
CVS Health Corporation provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals.
CVS Health Corporation stock opened the day at $90.64 after a previous close of $89.99. The latest price was $90.87 (25 minute delay). CVS Health Corporation is listed on the NYSE, has a trailing 12-month revenue of around USD$284 billion and employs 213,000 staff.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
Agilent Technologies stock opened the day at $157.29 after a previous close of $156.78. The latest price was $157.80 (25 minute delay). Agilent Technologies is listed on the NYSE, has a trailing 12-month revenue of around USD$6.3 billion and employs 17,000 staff.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health.
Hologic stock opened the day at $76.48 after a previous close of $76.62. The latest price was $76.56 (25 minute delay). Hologic is listed on the NASDAQ, has a trailing 12-month revenue of around USD$5.6 billion and employs 6,705 staff.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
Laboratory Corporation of America stock opened the day at $313.24 after a previous close of $313.34. The latest price was $314.21 (25 minute delay). Laboratory Corporation of America is listed on the NYSE, has a trailing 12-month revenue of around USD$16.6 billion and employs 70,000 staff.
Sign up with an online broker or platform to invest in one of more of these COVID testing stocks.
Note: The dollar amounts in the table below are in Canadian dollars.
Find out where to buy the Abbott Panbio rapid antigen test in Canada. Check out pricing, and get step-by-step instructions on how to use the test.
Here’s where you can find and book a PCR test, rapid antigen test, or buy a home testing kit in Ontario for Covid-19.
Boson Rapid Anitgen Tests are easy to use and tell you if you have COVID in around 15 minutes. Here’s our review and where to buy them.
Find out where to buy the Roche At-Home Rapid Antigen COVID-19 Test and learn what to expect from this testing kit.
Find QuickVue in stock and learn what to expect with a kit that offers you two tests for more conclusive results.
If you’re looking to travel abroad, you’re likely going to need a PCR test to prove that you’re COVID-free.
Find out how much a PCR COVID test in Canada costs, where to book a PCR test and more.
Sweden-based luxury car manufacturer, Volvo, is publicly trading on the Nasdaq Stockholm AB. Find out how to buy Volvo stock in Canada.
American depositary shares provide a simple way to invest in foreign companies on US stock exchanges. But there are pros and cons to consider.
We’ve rounded up stats on some of the most popular BNPL stocks, along with information on how they compare and how to invest.
You must be logged in to post a comment.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.